In the US, health plans commonly covered these drugs for diabetes or related conditions, but weight-loss-only prescriptions were much less likely to receive coverage.
Coverage often varied by plan type and formulary, with many plans requiring prior authorization and minimum BMI thresholds before approving medications for weight management.
Current individual market plans rarely covered weight-loss use, while employer coverage remained mixed: ~60% covered diabetes treatment, and ~35% covered both diabetes and weight loss.
The federal senior health program still excluded weight-loss-only use under its standard drug benefit, but a current pilot offered certain GLP-1 medications for $50/mo.
State-federal coverage also varied, so consumers were advised to review plan rules, appeal denials, and watch for coming changes in some programs.
Who Covers GLP-1 Drugs for Weight Loss?
